Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Innovative Kidney Health Product, Kidney C.O.P., Launched by Calcium Oxalate Labs, Inc. Helps Reduce Calcium Oxalate Crystal Stone Growth and Formation

99% Reduction In The Rate of Calcium Oxalate Crystal Stone Growth with Kidney C.O.P.(2)

Kidney C.O.P. Calcium Oxalate Protector - Patented Formula

News provided by

Calcium Oxalate Labs, Inc.

Apr 03, 2018, 10:07 ET

Share this article

Share toX

Share this article

Share toX

FORT LAUDERDALE, Fla., April 3, 2018 /PRNewswire/ -- Calcium Oxalate Labs, Inc., the maker of Kidney C.O.P. has begun marketing its new, patented dietary supplement for kidney health to the 20 million adults affected by calcium oxalate stones.1 The innovative Kidney C.O.P. formulation has been awarded four (4) U.S. Patents and has been optimized to inhibit the in vitro rate of calcium oxalate crystal stone growth by 99%.2 

    

Kidney C.O.P.'s Patented Formula Was Optimized Utilizing Hundreds Of  In Vitro Tests To Inhibit The Rate Of Calcium Oxalate Crystal Growth By 99%.
Kidney C.O.P.'s Patented Formula Was Optimized Utilizing Hundreds Of In Vitro Tests To Inhibit The Rate Of Calcium Oxalate Crystal Growth By 99%.
Kidney C.O.P. Has Demonstrated In Vitro To Be Five Times Stronger At Inhibiting The Rate Of Calcium Oxalate Crystal Growth Than The Chanca Piedra 5:1 Extract Dietary Supplement
Kidney C.O.P. Has Demonstrated In Vitro To Be Five Times Stronger At Inhibiting The Rate Of Calcium Oxalate Crystal Growth Than The Chanca Piedra 5:1 Extract Dietary Supplement
Compare Kidney C.O.P. To Chanca Piedra!
Compare Kidney C.O.P. To Chanca Piedra!

Kidney C.O.P. also offers many additional benefits:

  • The active ingredients in Kidney C.O.P. have been shown in clinical studies to support the inhibition of calcium oxalate crystal stone growth.3

  • Kidney C.O.P.'s formulation of active ingredients has been shown to be five times stronger at inhibiting the rate of calcium oxalate crystal stone growth when compared to Chanca Piedra Extract with a ratio of 5:1 (commonly known as Phyllanthus Niruri, Stone Breaker or Stone Crusher).5

  • Kidney C.O.P contains ingredients that allow the product to be taken each and everyday compared to chanca piedra, which is limited to 3 months .3,4,6

  • Four (4) of the five (5) active ingredients in Kidney C.O.P. are FDA GRAS (Generally Recognized As Safe) and the fifth ingredient is MUSA (banana stems), a source of food utilized for centuries worldwide.4

  • Kidney C.O.P. is free from any Preservatives, Artificial Colors, Flavors, Sweeteners, Sugars, Soy, Gluten, Wheat, Yeast, Fish and Sodium

  • To ensure its long-term potency, Kidney C.O.P. has been tested under Zone IV stability, the toughest of FDA stability testing conditions.

  • Kidney C.O.P. has been developed, formulated, patented and is encapsulated in the United States.

  • Doctors are already utilizing Kidney C.O.P. themselves and recommending Kidney C.O.P.

The CEO of Calcium Oxalate Labs, Inc., Gregory Hayer an experienced and successful pharmaceutical executive, has had many instances of calcium oxalate stones.  After several costly procedures, he decided that there must be a better way and enlisted the help of a doctor and other pharmaceutical executives to develop Kidney C.O.P.

Mr. Hayer states:

"I personally take Kidney C.O.P. every day to support my kidney health and inhibit calcium oxalate crystal stone growth. Kidney C.O.P. complements my doctor's recommendation to drink six 8 oz. glasses of water daily and consume a low oxalate diet. I have been pleased to learn that doctors have been personally taking Kidney C.O.P. and also recommending it to their patients."

For additional information, please visit KidneyCOP.com.

About the Company:

Calcium Oxalate Labs, Inc. is a privately-owned company. Further inquiries about the company or Kidney C.O.P. product can be directed through Customer Service at 1-800-586-9424 or "Contact Us' at KidneyCOP.com.

  1. https://www.ncbi.nlm.nih.gov/pubmed/22498635, http://eu-acme.org/europeanurology/upload_articles/Scales_July.pdf
  2. In vitro tests show that patented formula inhibits the rate of calcium oxalate crystal growth by 99%. Details can be found by reviewing patents 9,233,135 | 9,492,491 | 9,623,066 | and 9,789,152.
  3. These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat cure or prevent any disease. Caution: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur.
  4. GRAS Designations: Citric Acid (21 CFR 184.1033), Magnesium Citrate  (21 CFR 184.1449), Inositol (IP6) (Phytin) (Phytic Acid)  (21 CFR 184.1370), Pyridoxine Hydrochloride (21 CFR 184.1676), Ingredient Five (Common Food Item) | Musa paradisiaca, banana stems.
  5. https://kidneycop.com/wp-content/uploads/2018/03/Kidney-COP-vs-Chanca-Piedra-Calcium-Oxalate-Crystal-Growth-Testing-February-2018.pdf  
  6. https://www.webmd.com/vitamins-supplements/ingredientmono-441-chanca%20piedra.aspx?activeingredientid=441, https://www.rxlist.com/chanca_piedra/supplements.htm#SafetyConcerns

SOURCE Calcium Oxalate Labs, Inc.

Related Links

http://kidneycop.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.